SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ProMetic Life Sciences
An SI Board Since April 2016
Posts SubjectMarks Bans Symbol
250 11 0 PLI.TO
Emcee:  axial Type:  Moderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
75Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief 'U.S. Praxial-3/11/2017
74Excerpt : 2017 RBC Capital Markets’ Healthcare Conference Unconfirmed — no linkaxial-3/6/2017
73Prometic video — Progress update to March 2017 here. Jimaxial13/5/2017
72US FDA GRANTS ORPHAN DRUG DESIGNATION TO PROMETIC’S PBI-4050 DRUG FOR THE TREATMaxial13/3/2017
71Interesting article posted today on PLI website: -Early evidence of efficacy ofLeo Fisher12/22/2017
70NASDAQ and PROMETIC The following is a recent email sent to a Prometic investoraxial-2/20/2017
69Pediatric Priority Review Voucher — Regulatory Explainer: Everything You Need taxial-2/15/2017
682016 article — paid plasma collection in Canada Blood money: Legislated out of axial-2/15/2017
67CALIFORNIA CAPITAL EQUITY, LLC ACQUIRES 44 MILLION PROMETIC SHARES THROUGH THE Eaxial-2/6/2017
66Hi Leo - "Hematech most likely did not meet the strict manufacturing stanaxial-2/1/2017
65EUROPEAN COMMISSION GRANTS ORPHAN DRUG DESIGNATION TO PROMETIC’S PBI-4050 DRUG Faxial-2/1/2017
64PROMETIC’S PBI-4050 RECEIVES PROMISING INNOVATIVE MEDICINE DESIGNATION FROM THE axial-2/1/2017
63PROMETIC REACQUIRES PLASMINOGEN RIGHTS FROM HEMATECH Regains 100% ownership of axial-2/1/2017
62Rick, it's an interesting stock -- to trade, or as a buy and hold. Good to haxial-2/1/2017
61Peanuts to reacquire rights, modest royalty going forward. -Hematech most likelyLeo Fisher-1/10/2017
60Jim... thanks for bringing this company to our attention. I position trade, scaram(o)uche-1/10/2017
59Today's move is wonderful, but it again leaves me with the feeling that Iscaram(o)uche-1/5/2017
58I get the high market cap / hemorrhaging of cash, but that's not unusual forLeo Fisher-1/5/2017
57there is also this..... ncbi.nlm.nih.govscaram(o)uche-1/5/2017
56from Tefs et al, 2003..... the K19E mutation in the plasminogen gene is a comscaram(o)uche-1/4/2017
55Well.... fairly large market cap, no cash. Cash runway will last until imporscaram(o)uche-1/4/2017
54I have never really done shorts but is it just me or is shorting at this currentLeo Fisher-1/4/2017
53117K block fell at 11:50, $1.72 Short interest (pfscf) up whompers, last reportscaram(o)uche-1/3/2017
52PLASMINOGEN CORPORATE UPDATE VIDEO ' Please find below a link to a short caxial-12/22/2016
51Wasn't aware of that one, it's new. Good find! Jimaxial-12/20/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):